Home » Newsletters » BioWorld

BioWorld

July 8, 1993

View Archived Issues

IMMUNE RESPONSE REGISTERS SHARES

XYTRONYX RAISES $1.74 MILLION

TRIPLEX COLLABORATES WITH WISTAR RESEARCHER

VESTAR STARTS TRIALS

INTERLEUKIN SAVES MICE

OXFORD COMPLETES FUND-RAISING

GENICA READIES CMT DIAGNOSTIC

TRIALS OF DENTAL COMPOUND APPROVED

OPPOSITION FORMS AGAINST MEDICAID FORMULARIES

EPA REGISTERS ECOGEN BIOPESTICIDE

COLLABORATIVE SELLS TESTING BUSINESS

AGOURON HALTS TRIALS ON DRUG FOR PSORIASIS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...